Vivus’ Diet Pill Meets Goals, Is Safe in Weight-Loss Study (Bloomberg)
Sept. 9 (Bloomberg) — Vivus Inc . said its experimental weight-loss drug Qnexa helped patients lose enough weight in studies to allow the biotechnology company to seek U.S. approval to sell the treatment this year.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
